GeneDx (WGS) had its price target lowered by Guggenheim from $170.00 to $100.00. They now have a "buy" rating on the stock.
Assessing GeneDx Holdings (WGS) Valuation After Recent Share Price Weakness [Yahoo! Finance]
Is GeneDx Holdings (WGS) Pricing In Its Sharp 27% Weekly Share Price Move? [Yahoo! Finance]
GeneDx to Launch Genetic Testing Program with Zevra Therapeutics to Support Patients with Suspected Niemann-Pick Disease Type C
A Look At GeneDx Holdings (WGS) Valuation After Strong Earnings And Genomics AI Developments [Yahoo! Finance]